Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Researchers Discover What Lies Behind the Death of Stem Cells
Researchers have identified key processes that control stem cell survival, providing insights that could improve their use in medicine.
Genetic Testing for Prostate Cancer
Genetic testing can identify men at six-fold increased risk of prostate cancer.
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Leukemia Subtype Becomes More Common With Age
Genomic Analysis of 1,725 patients reveals the prevalence of Ph-like ALL increases with age.
Ovarian Cancer Oncogene Found in "Junk DNA"
The study is published online in this week in Cancer Cell.
New Genetic Target for a Different Kind of Cancer Drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that is drastically reduced in human lung and breast cancer cells.
Combination microRNA Therapy Suppresses Non-Small-Cell Lung Cancer
Findings offer a promising therapeutic avenue for NSCLC.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
New Gene Mutations for Wilms Tumor
UT Southwestern researchers identified the mutated genes by sequencing the DNA of 44 tumors.
Scroll Up
Scroll Down
Return
Comprehensive microRNA Expression Profiling in Lineage Specific Human Hematopoiesis
Nalini Raghavachari, NIH, speaking at Genomics Research 2013.
Date Posted: Tuesday, June 18, 2013
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



NIH Announces the Launch of 3 Integrated Precision Medicine Trials
ALCHEMIST is for patients with certain types of early-stage lung cancer.
Tuesday, August 26, 2014
NIH Launches 3 Integrated Precision Medicine Trials
Findings to answer questions about addition of targeted therapies in earlier stage disease and help understand the prevalence and natural history of these genomic changes in earlier stage lung cancer.
Wednesday, August 20, 2014
GTEx Project to Expand Functional Studies of Genomic Variation
Larger set of human tissues to be analyzed to contribute to a database and tissue bank that researchers can use to study how genomic variants influence gene activity.
Wednesday, August 06, 2014
Study Identifies Novel Genomic Changes in the Most Common Type of Lung Cancer
TCGA finds mutations in a key cancer-causing pathway, expanding targets for existing drugs.
Thursday, July 10, 2014
Low Doses of Arsenic Cause Cancer in Male Mice
NIH researchers found that arsenic in drinking water develop lung cancer.
Thursday, July 10, 2014
Brain Tumor Invasion Along Blood Vessels May Lead to New Cancer Treatments
NIH-funded researchers find brain tumor cells disrupt the brain’s protective barrier, offering potential avenues for therapy.
Thursday, July 10, 2014
Clark Atlanta University Awarded $7.4M NIH Cancer Research Grant
Clark Atlanta University in Atlanta was awarded a $7.4 million renewal grant for the Center for Cancer Research and Therapeutic Development (CCRTD).
Wednesday, May 14, 2014
Unexpected Protein Partnership has Implications for Cancer Treatment
Scientists have identified a macrophage that works together in response to cancer drugs to increase inflammation in a way that may alter tumor growth.
Tuesday, April 15, 2014
Obesity Primes the Colon for Cancer, According to NIH Study
The study appeared online April 1 in the journal Cell Metabolism.
Saturday, April 05, 2014
Regular Aspirin Use May Reduce Ovarian Cancer Risk
Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study from the National Cancer Institute.
Friday, February 07, 2014
NIH Study Offers Insight into Why Cancer Incidence Increases with Age
NIH researchers identified DNA methylation sites across the human genome that changed with age.
Tuesday, February 04, 2014
NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes
Trial could identify patient sub-groups that are likely to benefit from certain treatments.
Saturday, February 01, 2014
NIH Scientists Map Genetic Changes that Drive Tumors in Rhabdomyosarcoma
The genetic alterations identified could be useful in developing targeted diagnostic tools and treatments for children with the disease.
Monday, January 27, 2014
Gene-Silencing Data Now Publicly Available to Help Scientists Better Understand Disease
NIH data-sharing collaboration with Life Technologies will advance genetic and translational research, therapeutic target discovery.
Thursday, December 12, 2013
NIH, Life Tech Collaboration Makes Gene-Silencing Data Publicly Available
NIH data-sharing collaboration with Life Technologies will advance genetic and translational research, therapeutic target discovery.
Wednesday, December 11, 2013
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv